VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 0952008
Sex: F
Age:
State: PA

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: arm really hurt; stomach cramping; didn't feel well; This is a spontaneous report from a non-contactable Nurse anesthetist reporting for herself via Pfizer employee (friend). A 46-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 08Jan2021 at 08:00 at single dose for COVID-19 immunisation. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number EK5730) received via an unspecified route of administration on 18Dec2020 at 08:00 at single dose. The patient was taking COVID-19 vaccine since is front line healthcare worker. The patient was vaccinated at hospital. Age at vaccination was 46 years. The patient's medical history and concomitant medications were not reported. The patient reported she had no problems with the first dose but after the second dose that night (08Jan2021) her arm really hurted and she had stomach cramping. She didn't feel well at all. The patient took two Advil and the next day (09Jan2021) she was fine and is still fine. The Pfizer employee stated her friend looked fine as she was exercising. Onset date of the events was also reported as 09Jan2021 with recovery date 10Jan2021. No follow-up attempts are possible; Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0952009
Sex: F
Age:
State:

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Name: body temeprature; Result Unstructured Data: Test Result:101.7; Test Name: body temeprature; Result Unstructured Data: Test Result:99.5

Allergies:

Symptoms: Breast feeding/first dose 24Dec2020 14:30/second dose 11Jan2021 07:30; She was also breast feeding; first dose 24Dec2020 14:30/second dose 11Jan2021 07:30; Fever of 101.7/ temp is still a little elevated at 99.5; full body aches; Chills; Headache; Breast feeding and experienced painful let down; This is a spontaneous report from a non-contactable nurse (patient) reported for herself. This Nurse reported information for both herself and her baby. This is a mother report. A 33-years-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot: EL1283) via an unspecified route of administration on 11Jan2021 07:30 at single dose for COVID-19 immunization. The patient received the first dose on 24Dec2020 14:30 at age of 33 years old at single dose for COVID-19 immunization, and only had a sore arm and maybe fatigue. Medical history included ongoing breast feeding, asthma, Anaphylaxis to tree nuts. Concomitant medication included bifidobacterium lactis (PROBIOTIC) and prenatal multivitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced fever of 101.7, full body aches, chills, headache. She was also breast feeding and experienced painful let down at the time (she did not have mastitis). She had all these symptoms on 11Jan2021 16 hrs after receiving second dose. Now at 24 hours all symptoms have resolved except her temp is still a little elevated at 99.5. No treatment was received for the adverse event. Events outcome of full body aches, chills, headache, painful let down at the time (breast feeding) was recovered, for fever was recovering, while for others was unknown. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021027460 Mother/Baby case

Other Meds: PROBIOTIC [BIFIDOBACTERIUM LACTIS]

Current Illness: Breast feeding

ID: 0952010
Sex: M
Age:
State: NY

Vax Date: 12/23/2020
Onset Date: 12/27/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Shingles; This is a spontaneous report from a contactable physician reported for himself. A 56-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231, expiration date was not reported), via an unspecified route of administration on the left arm on 23Dec2020 07:30 at single dose for COVID-19 immunization. Medical history was reported as none. The patient has no allergies to medications, food, or other products. The patient received 'rovoustatin' within two weeks of vaccination. The patient experienced shingles on 27Dec2020. The patient received Valtrex as treatment for the event. The patient did not receive any other vaccine within four weeks prior to COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient has not been tested for COVID-19 since the vaccination. The patient recovered from the event on an unspecified date.

Other Meds:

Current Illness:

ID: 0952011
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: She had rashes all over the body; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored program. A female patient of an unspecified age received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced she had rashes all over the body on an unspecified date with outcome of unknown. Information about lot and batch number was requested.

Other Meds:

Current Illness:

ID: 0952012
Sex: F
Age:
State: CO

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Date: 20210107; Test Name: fever; Result Unstructured Data: Test Result:101.5 at 05:45; Test Date: 20210107; Test Name: fever; Result Unstructured Data: Test Result:it came down a little bit, it's tolerable

Allergies:

Symptoms: I have a fever, it maxed of this morning at 101.5; Nauseous; Body ache; Arm hurts; Chills; This is a spontaneous report from a contactable nurse (patient). This 50-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot # EK9231), via an unspecified route of administration, on 06Jan2021 at 5:15 at single dose for COVID-19 immunisation. Vaccine location was left shoulder. The patient was vaccinated at hospital, age at vaccination was 50-years-old. Medical history and concomitant medications were none. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE an unknown date. Nurse stated she was just reporting some side effects from COVID Vaccine. She had second one last night at 5:15 and she is a nurse and she worked over night which she would never do that again. So, she has a fever, it maxed of this morning at 101.5 and chills, body ache, and she feels nauseous, and her arm hurts. Nausea was first at about 1:30 in this morning (07Jan2021) and then chills and then fever by about quarter to 6 this morning (07Jan2021), she started to check her temperature. Outcome was not recovered. No treatment was received for the events. She just didn't wanted to mask the fever. She wanted to see how it developed and her highest temperature was 101.5, then it came down a little bit, it's tolerable. About causality, nurse stated Yeah, most definitely.

Other Meds:

Current Illness:

ID: 0952013
Sex: F
Age:
State: VA

Vax Date: 01/06/2021
Onset Date: 01/01/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: I felt tingling like kind of about 10 minutes after having the vaccine as I was standing there, I felt a little tingly.; little zingy feeling in my left pinky and ring finger; Pain injection site; This is a spontaneous report from a contactable physician (patient). A 50-year-old female patient receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), via an unspecified route of administration at left arm on 06Jan2021 at single dose for COVID-19 immunization. The patient medical history included was none. The patient's concomitant medications were not reported. The patient reported: " pain injection site" and "I felt tingling like kind of about 10 minutes after having the vaccine as I was standing there, I felt a little tingly. I had the vaccine in my left arm in my right hand I had a little tingly feeling and I was like well maybe because I am holding my pocket book on that side I shifted over, at work I am getting like just a little zingy feeling in my left pinky and ring finger". The patient outcome of the events was unknown.

Other Meds:

Current Illness:

ID: 0952014
Sex: F
Age:
State:

Vax Date: 01/08/2021
Onset Date: 01/01/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: sore arm; This is a spontaneous report from a Pfizer Sponsored program. This is a spontaneous report from a contactable consumer. A female patient of an unspecified age started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# unknown), via an unspecified route of administration on 08Jan2021 at single dose for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced a bit of sore arm in Jan2021. The outcome was unknown Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0952015
Sex: U
Age:
State: MS

Vax Date:
Onset Date:
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Mild arm pain; Headache; Fatigue; This is a spontaneous report from non-contactable nurse (patient) received via a Pfizer sales representative. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced mild arm pain, headache and fatigue. The patient outcome of the events was recovered. No follow-up attempts are possible, information about batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0952016
Sex: F
Age:
State:

Vax Date: 01/06/2021
Onset Date: 01/01/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: soreness in upper arm; This is a spontaneous report from a contactable consumer reporting for herself. A female patient of an unspecified age received bnt162b2 (BNT162B2) vaccine, via an unspecified route of administration from on 06Jan2021 at single dose for Covid-19 immunisation . The patient medical history and concomitant medications were not reported. The patient experienced soreness in upper arm on Jan2021 with outcome of unknown. Information about Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 0952017
Sex: F
Age:
State: NJ

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Date: 202004; Test Name: COVID; Test Result: Positive

Allergies:

Symptoms: felt a little bit warm and itchy in her chest area; felt a little bit warm and itchy in her chest area; Rash/ rashes in her neck and chest area; swollen lymph node in armpit area; soreness/pain at injection site; This is a spontaneous report from a contactable nurse (patient). A 31-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1686, expiration date: Mar2021), intramuscular in the left arm on 07Jan2021 at 0.3 mL, single dose for COVID-19 immunization. Medical history included testing positive for COVID in Apr2020. There were no concomitant medications. The patient previously took flu shot and experienced soreness. The patient did not receive any vaccination within 4 weeks prior to the COVID vaccine. The patient called in regards to Pfizer COVID Vaccine. She received her first vaccine last Thursday, 07Jan2021. She was not sure if she can report this as a side effect, but she had some rashes appear just today (11Jan2021), at midnight, in her neck and chest area. The rashes were going away, but she still has some itching. She also stated that she took some over-the-counter diphenhydramine (BENADRYL, UPC: 1254717031, lot number: PJF044, expiration date: Jun2021) tablets to relieve the symptoms. She explained that she started to experience soreness/ pain at the injection site a few hours after receiving the COVID-19 vaccine. The pain in her arm has already went away. She noticed a swollen lymph in her armpit area on Friday morning, 08Jan2021 and it's still a little bit swollen. She didn't expect on getting a rash since she read symptoms only appear around 2-3 days only. Therefore, she is not sure if she can report this as a side effect because its been like 3 days already. She noticed the rash just today, at midnight. She stated that she is still itchy. She stated that there is just a little bit of itchiness in her neck. She felt a little bit warm and itchy in her chest area, at midnight (unspecified date), and she kept scratching. She knows she shouldn't have done that but it was itchy. The patient would consider these events to be non-serious. She did have some soreness with a flu shot before so it's not too serious. She explained she is a healthcare worker. She works in a nursing home facility and they asked if she wanted to receive the Covid-19 vaccine and she filled out the form. She also explained that she doesn't have any allergies to any medications. So, with the rashes that came, she is not really sure what is the cause of it. The events did not require a visit to the emergency room or physician office. She stated she wanted to report this information but she also needs advice on whether she needs to continue taking Benadryl. Her rash is improving, but she is still a little bit itchy. She doesn't have any shortness of breath or anything. It's not a major reaction, just a little bit of a rash/itchiness in her chest and neck area. The outcome of the event vaccination site pain was recovered on 10Jan2021, for lymphadenopathy and rash was recovering, for pruritus was not recovered and for feeling hot was unknown.

Other Meds:

Current Illness:

ID: 0952018
Sex: F
Age:
State: MA

Vax Date: 12/18/2020
Onset Date: 12/01/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: localized pain at the injection site; This is a spontaneous report from a contactable consumer (patient). A 28-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK5730, expiration date: Mar2021), via an unspecified route of administration on 18Dec2020 at a single dose to prevent COVID-19. The patient had no medical history. There were no concomitant medications. The patient got the second dose of the Covid-19 vaccine on Friday, 08Jan2021 (lot number: EK9231, expiration date: Apr2021). She didn't have a fever or chills, but she had localized pain which she also had with the first dose. She still has pain in her armpit, to the touch and when she moves it, but there is no swelling, lumps or bumps. The pain has decreased; it's not as bad as it was when she first noticed it. The localized pain at the injection site was worse with the first injection in Dec2020; she just did not have the underarm pain and she didn't have any pain until the day after she got the first dose. She got the 2nd dose at 5:30pm, and had pain at around 8pm or 9pm that night. The following day was the height of the pain for the second dose, and it has been decreasing since then. She got both doses in her left arm. Outcome of the event was unknown.

Other Meds:

Current Illness:

ID: 0952019
Sex: F
Age:
State:

Vax Date: 12/18/2020
Onset Date: 01/02/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Injection site tenderness for first 24 hours; swollen lymph glands; This is a spontaneous report from a non-contactable consumer (patient). A 32-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on the left arm on 18Dec2020 11:00 at single dose for COVID-19 immunization. Medical history included tumor removal from left thigh and depression. The patient had no known allergies. Concomitant medication included bupropion hydrochloride (WELLBUTRIN), drospirenone, ethinylestradiol (OCELLA), clonazepam, amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]). On 02Jan2020, patient reported injection site tenderness for first 24 hours. In less than 24 hours she had developed tenderness under her left arm, into her armpit and it continued to spread downward and also toward her breast. Patient also developed swollen lymph glands in the same areas. No treatment received in response to the events. The patient had no COVID prior to vaccination and not COVID tested post vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The events were reported as non-serious. The patient received her second dose of bnt162b2 on 08Jan2021 11:00 in the left arm. Outcome of the events was not recovered. No follow-up attempts are possible; Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: WELLBUTRIN; OCELLA; ; ADDERALL; ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 0952020
Sex: F
Age: 33
State: MI

Vax Date: 12/20/2020
Onset Date: 01/09/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: none

Allergies: vancomycin-induced redman syndrome kiwi elicits pruritic throat palm oil elicits dermatitis

Symptoms: minor side effect: night of injection had vivid dream, and 2nd night after injection had another vivid dream when I do not typically have dreams minor side effect of some chills 13 hours after injection that slight worsened, persisting until 36 hours after injection (resolved 1.5 days after injection) moderate pain at site of injection, onset 5 hours after injection and lasting until 2.5 days after injection

Other Meds: Glucosamine HCL 1500mg qD Chondroitin sulfate 1200mg qD collagen 6,000 mg supplement that also incl vitamin c 60mg qD daily vitamin kirkland mature 50+ that does not include iron qD Ferrous sulfate 325mg qD magnesium 250mg qD cetirizine 10

Current Illness: N/a

ID: 0952021
Sex: F
Age:
State: TX

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Stiffness on the right arm where she got the vaccine shot that is painful; Stiffness on the right arm where she got the vaccine shot that is painful; Cold chills; Body aches; This is a spontaneous report from a contactable consumer. A 51-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; lot number: SJ1865), via an unspecified route of administration on 06Jan2021 10:00 at SINGLE DOSE at right arm for COVID-19 immunization. Medical history included ongoing Diabetic- Started 4-5 years ago. Concomitant medication included ongoing metformin for diabetic. The patient clarified the side effects she experienced were cold chills, body aches, and stiffness on the right arm where she got the vaccine shot and there was pain. The cold chills started late afternoon on 06Jan2021 around 1:00 PM or 1:30PM. She confirmed these have gone away and she has recovered completely. The body aches started around this same time as well. The stiffness on the right arm where she got the vaccine shot is painful. She noticed the stiffness and pain about 30 minutes after she got the vaccine, it was like 10:30 AM when she noticed this. She is no longer hurting and the stiffness has gone away. It went away on Saturday late in the evening like 7:00PM or 8:00 PM. The outcome of the events was recovered on 09Jan2021.

Other Meds:

Current Illness: Diabetic (Diabetic- Started 4-5 years ago)

ID: 0952022
Sex: F
Age:
State: IL

Vax Date: 12/20/2020
Onset Date: 12/20/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Dizziness; Weakness; Tiredness; This is a spontaneous report from a contactable consumer who reported for herself, a 56-year-old female patient who received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 20Dec2020 at a single dose with lot number: EJ1685, and the second dose via an unspecified route of administration on 10Jan2021 at a single dose with lot number: EL3248, for COVID-19 immunization. The patient had no medical history nor concomitant medications. When patient had the first vaccine on 20Dec2020, she experienced dizziness, weakness and tiredness which lasted for 4 days. The outcome of the events was recovered with sequelae, patient received the second dose of the Covid-19 vaccine on 10Jan2021, she was also having dizziness, weakness and tiredness which were ongoing at the time of report.

Other Meds:

Current Illness:

ID: 0952023
Sex: F
Age: 65
State: DC

Vax Date: 01/16/2021
Onset Date: 01/17/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: 100? temp Swollen hands and feet Headache

Other Meds:

Current Illness:

ID: 0952024
Sex: F
Age:
State: TX

Vax Date: 01/04/2021
Onset Date: 01/08/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: limping one side of foot; wanted to pass out; numbness to right side of face; every muscle in her body hurts; stomach is cramping; This is a spontaneous report from a contactable consumer. A 60-years-old female patient started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL0140) , via an unspecified route of administration on 04Jan2021 at the first single dose at Arm Left for covid-19 immunisation . Medical history reported as none. There were no concomitant medications. The patient experienced wanted to pass out, numbness to right side of face, every muscle in her body hurts, stomach is cramping on 08Jan2021, limping one side of foot on 11Jan2021. The outcome of event wanted to pass out was unknown; outcome of event numbness to right side of face, stomach is cramping, limping one side of foot was not recovered; outcome of event every muscle in her body hurts was recovering;

Other Meds:

Current Illness:

ID: 0952025
Sex: M
Age:
State: AZ

Vax Date:
Onset Date:
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Name: tested; Test Result: Positive

Allergies:

Symptoms: developed symptoms for Covid/tested positive after receiving the vaccine; developed symptoms for Covid/tested positive after receiving the vaccine; developed symptoms for Covid/tested positive after receiving the vaccine; This is a spontaneous report from a contactable physician (patient) and a consumer (patient's spouse). A 67-year-old male patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; lot number: EH9899; expiration date: not known), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The physician had a question. As a patient, he received the first dose of Pfizer BioNTech vaccine and on an unspecified date, two days later, he developed symptoms for Covid and tested positive after receiving the vaccine. He stated this had nothing to do with vaccine but had to do with the timing. He wanted to know if should take or delay vaccine. He is doing fine now. His second dose is coming up next week. The outcome of the events was recovered on an unspecified date.; Sender's Comments: The association between the event lack of effect (he developed symptoms for COVID and tested positive) with BNT162b2 can not be completely excluded.

Other Meds:

Current Illness:

ID: 0952026
Sex: F
Age:
State: OK

Vax Date: 01/06/2021
Onset Date: 01/01/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Name: Covid-19 test; Result Unstructured Data: Test Result:non-detectable

Allergies:

Symptoms: First dose administered on 18Dec2020; received second dose at Day 20; Low grade fever; Malaise; Change in smell/sense of smell worse; Change in smell/sense of smell worse; This is a spontaneous report from a Pfizer-sponsored program. A contactable healthcare professional (patient) reported that a female patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on 06Jan2021 at a single dose, with route of administration unspecified, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 18Dec2020 for COVID-19 immunization, and had severe malaise, muscle aches, pain in injection site (arm), and had change in smell which was described as a foul burnt smell. The patient had received the second dose of the vaccine on 06Jan2021 (day 20). In Jan2021, the patient had low grade fever; malaise; and change in smell/sense of smell had worsened. The patient's COVID-19 test was non-detectable on an unspecified date. The outcome of the events, 'low grade fever', 'malaise', 'change in smell/sense of smell had worsened' and 'received the second dose of the vaccine on 06Jan2021 (day 20)', was unknown. Information on lot number/batch number was requested.

Other Meds:

Current Illness:

ID: 0952028
Sex: U
Age:
State: NJ

Vax Date:
Onset Date:
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Name: tested; Test Result: Positive

Allergies:

Symptoms: got the first vaccine and then tested positive for the virus; got the first vaccine and then tested positive for the virus/fairly sick; This is a spontaneous report from Pfizer-sponsored Program IBCC (Inbound Call Center for HCPs). A contactable physician reported similar events for two patients. This is the first of two reports. A patient of unspecified age and gender received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; lot number and expiration date: not known), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter is a cardiologist. He is inquiring about the COVID-19 vaccine. He had several patients (pending clarification) who got the first vaccine and then tested positive for the virus. He is asking when can they get the second dose after testing positive. He had two patients that are fairly sick now. He has had patients who have monochromal antibodies (pending clarification). He is asking when they can get the vaccine after that treatment. The outcome of the events was unknown. Information about lot/batch number has been requested.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation between vaccination and onset of events.,Linked Report(s) : US-PFIZER INC-2021022171 same reporter, similar suspect drug and event; different patient

Other Meds:

Current Illness:

ID: 0952029
Sex: U
Age:
State: NJ

Vax Date:
Onset Date:
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Name: tested; Test Result: Positive

Allergies:

Symptoms: got the first vaccine and then tested positive for the virus; got the first vaccine and then tested positive for the virus/fairly sick now; This is a spontaneous report from Pfizer-sponsored Program. A contactable physician reported similar events for two patients. This is the second of two reports. A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; lot number and expiration date: not known), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter is a cardiologist. He is inquiring about the COVID-19 vaccine. He had several patients (pending clarification) who got the first vaccine and then tested positive for the virus. He is asking when can they get the second dose after testing positive. He had two patients that are fairly sick now. He has had patients who have monochromal antibodies (pending clarification). He is asking when they can get the vaccine after that treatment. The outcome of the events was unknown. Information about lot/batch number has been requested.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation between vaccination and onset of events.,Linked Report(s) : US-PFIZER INC-2021022153 same reporter, similar suspect drug and event; different patient

Other Meds:

Current Illness:

ID: 0952030
Sex: F
Age:
State: NC

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: altered taste; altered sense of smell; slight left arm soreness; slight headache; This is a spontaneous report from a contactable consumer (patient). A 75-years-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL1283 and expiration date not provided), via an unspecified route of administration left arm first dose on 08Jan2021 at single dose for covid-19 immunisation. There were no medical history and concomitant medications. It was reported that patient got the first shot of the Pfizer Covid 19 vaccine last Friday 08Jan2021. Stated that she had normal slight arm soreness and slight headache on Saturday 09Jan2021. Stated that she woke up this morning 11Jan2021 and had altered taste and sense of smell. Stated that she has not heard of this as reaction to the shot. Stated that she feels fine. Stated that she put on perfume that was old and fixed grits with cheese which she could barely taste. Stated that she tried other things and noticed that she has altered sense of taste and smell. The patient did not received treatments for the events. The outcome of the events slight left arm soreness and slight headache was recovered on 09Jan2021 and not recovered for the other events.

Other Meds:

Current Illness:

ID: 0952031
Sex: F
Age: 27
State:

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies: NKDA

Symptoms: Pt developed headache a few hours after vaccine that persisted for 3 days despite over the counter analgesics and greatly improved after an IM injection of Toradol 30mg on 1/14/21. Pt also had myalgias and grogginess that was self-limited.

Other Meds: Zyrtec 10mg daily PRN, ibuprofen PRN, Tylenol PRN

Current Illness: None

ID: 0952032
Sex: F
Age:
State: IL

Vax Date: 12/19/2020
Onset Date: 12/19/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fatigue; low grade fever; reddening on her face on the nasal labial area or smile line area; a very sore left arm for a day; a very sore left arm for a day and swelled up a little; This is a spontaneous report from a contactable nurse. A 63-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number: EJ1685), via an unspecified route of administration on the left arm on 19Dec2020 16:15 at SINGLE DOSE for COVID-19 immunization at the hospital. It was reported that the patient was menopausal. Ongoing medical histories included gastrooesophageal reflux disease (GERD), iron deficiency (reported as iron supplementation), sinus disorder, hypersensitivity; and hair disorder, nail disorder and immune system disorder (reported as help with hair and nail and immune system). Ongoing concomitant medications included fexofenadine hydrochloride (ALLEGRA) since unknown date (reported as taking for a year) for sinus and allergies, calcium (CALCIUM) since unknown date (reported as taking for a year) for menopause, famotidine (FAMOTIDINE) since unknown date (reported as taking for a year) for GERD, cyanocobalamin (VITAMIN B12) since unknown date (reported as taking for a year) to help with hair and nail and immune system, colecalciferol (VITAMIN D 3) since unknown date (reported as taking for a year or two) for menopause and multivitamin since unknown date (taking for 5 years at least). The patient received the first dose of the Pfizer COVID 19 vaccine on 19Dec2020 at 1615PM in the left arm. She then reported of a very sore left arm for a day and it swelled up a little on that same day. She then felt some fatigue a little the next day (20Dec2020) on Sunday but it didn't prevent her from going to work. On 20Dec2020 to 21Dec2020 (Sunday to Monday), she noticed a low-grade fever for a maybe 12 hours but she couldn't find a thermometer and doesn't know her temperature. She also developed a reddening on her face on the nasal labial area or smile line area but not very pronounced on 20Dec2020 (noticed it for about 8 to 12 hours). All of her symptoms resolved by the 21Dec2020. The events does require a visit to physician office or emergency room (ER).

Other Meds: ALLEGRA; ; ; VITAMIN B12 [CYANOCOBALAMIN]; VITAMIN D 3

Current Illness: Allergy; GERD; Hair disorder; Immune system disorder; Iron deficiency; Menopausal; Nail disorder; Sinus disorder

ID: 0952033
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: chills; felt icky; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration from an unspecified date at a SINGLE DOSE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 for covid-19 immunization (1st dose). The patient experienced chills and felt icky on an unspecified date after the second dose. The outcome of event was unknown. Follow-up attempts are completed. The following information on the batch number has been requested.

Other Meds:

Current Illness:

ID: 0952034
Sex: F
Age:
State: IL

Vax Date: 01/09/2021
Onset Date: 01/01/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Date: 20210110; Test Name: fever; Result Unstructured Data: Test Result:99.4 Fahrenheit

Allergies:

Symptoms: fever 99.4; muscle and bone aches; muscle and bone aches; wasn't feeling good; This is a spontaneous report from a contactable nurse (patient). A 63-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL3248 and expiry date: unknown), via an unspecified route of administration on 09Jan2021 15:50 at a single dose for COVID-19 immunization. Medical history included menopausal, GERD, sinus disorder, and allergies. Concomitant medications included colecalciferol (VITAMIN D 3) taking for a year or two for menopausal, cyanocobalamin (VITAMIN B12) taking for a year to help with hair, nail, and immune system, calcium taking for a year for supplementation and menopausal, famotidine taking for a year for GERD, fexofenadine hydrochloride (ALLEGRA) taking for a year for sinus and alllergies, and unspecified multivitamin taking for 5 years at least for iron supplementation. The patient received the first dose of bnt162b2 (lot number: EJ1685) on 19Dec2020 at 16:15PM in the left arm. She had a very sore left arm for a day and it swelled up a little. She felt some fatigue a little the next day on 20Dec2020 Sunday but it didn't prevent her from going to work. 20Dec2020 to 21Dec2020 (Sunday to Monday), she noticed a low grade fever for maybe 12 hours but she couldn't find a thermometer and did not know her temperature. She developed a reddening on her face, but it was not very pronounced, on the nasal labial area or smile line area. It was more pronounced on the first dose, she noticed it for about 8 to 12 hours Sunday 20Dec2020. All of her symptoms resolved by 21Dec2020. She received the second dose 9Jan2021 at 15:50PM in the left arm. She noticed nothing right away but maybe 6 hours later, her left arm was very sore. She had more of a fever which she measured at 99.4 Fahrenheit on 10Jan2021. Her normal is 97.1 to 97.5 Fahrenheit which she knew because she had to get screened at work. This time, after the second dose, she also noticed she had bone and muscle aches but was all short lived on 10Jan2021. She went to church and wasn't feeling good from about 10:00AM to about 19:00PM. She did treat the fever and muscle/bone aches with Tylenol extra strength rapid relief 500mg each. She took two by mouth once 3 hours before the vaccine and again once during the night and once yesterday 10Jan2021 afternoon for a total of three times and it did help. She also rested on Sunday 10Jan2021 afternoon, took extra fluids so by the time she had to go to work she felt normal. The vaccine was not administered at military facility. No additional vaccines were administered on same date of bnt162b2. The adverse events did not require a visit to the physician's office or ER. There were no prior vaccinations (within 4 weeks). The patient had no family medical history relevant to the adverse events. Outcome of the event wasn't feeling good was unknown and of the other events was recovered on 10Jan2021.

Other Meds: VITAMIN D 3; VITAMIN B12 [CYANOCOBALAMIN]; ; ; ALLEGRA

Current Illness:

ID: 0952035
Sex: F
Age:
State: CA

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: chest congestion; throat hurts; arm hurt; body aches; Weakness; Headache; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ELI283, expiration date not reported), via an unspecified route of administration on 08Jan2021 at single dose for COVID-19 immunization. Medical history included 'Blood pressure'. Concomitant medication included doxorubicin hydrochloride (LIPISOL) for blood pressure. The patient reported that on 08Jan2021 (Friday), she had the COVID vaccine. On 09Jan2021 (Saturday), her arm hurt, she had body aches, and weakness. She also had a headache Saturday night. On 10Jan2021, she started getting chest congestion and her throat was hurting. When she was spitting out it felt like her throat was scratchy. Patient further reported that her arm does not hurt now. It still bothers her a little if she touches it, but doesn't if she doesn't touch it. Patient also reported that she does not have too much body aches now. She had a good dinner and took two of the 600mg Ibuprofen. It helped her. It still hurts a little. Patient reported that her weakness feels a little better. No fever and she has been checking her temperature. Patient clarified that her throat wasn't bothering her last night, but today it was bothering her. It was the bottom of her throat. She was supposed to go back on the 29th to get the other part. The patient was recovering from arm hurt, body aches, and weakness; has not recovered from chest congestion; and unknown outcome for the remaining events.

Other Meds: LIPISOL

Current Illness:

ID: 0952036
Sex: M
Age:
State: IL

Vax Date:
Onset Date: 01/07/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Date: 20210107; Test Name: Temp; Result Unstructured Data: Test Result:100.4

Allergies:

Symptoms: nausea; vomiting; Temp of 100.4; This is a spontaneous report from a non-contactable healthcare professional. An elderly male patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140) solution for injection, via an unspecified route of administration on an unspecified date at a single dose for Covid-19 immunization. Medical history included Covid-19 (patient was diagnosed with COVID-19 prior to vaccination). The patient's concomitant medications were not reported. The patient experienced nausea, vomiting, and a temp of 100.4 on 07Jan2021. Since the vaccination, the patient has not been tested for COVID-19. Outcome of the events was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 0952037
Sex: M
Age:
State: RI

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Itching; Rash/all over the body, face, neck and back; Fever; This is a spontaneous report from a contactable consumer reported for himself. A 42-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in left arm on 08Jan2021 10:30 at single dose for covid-19 immunisation. Medical history included diabetes. Concomitant medication included varicella zoster vaccine (VARICELLA VACCINE). He noticed a rash on Saturday 09Jan2021 all over the body, face, neck and back; and he had fever. Did not take his temperature. Now today the rash is itching and getting worse. He is planning to get the next injection in 21 days. Mentions he showed the rash to the nurse who gave him this number to call. Information on the Lot/Batch number has been requested. Outcome of event fever was recovered, of others was not recovered.

Other Meds: VARICELLA VACCINE

Current Illness:

ID: 0952038
Sex: F
Age:
State: CT

Vax Date: 12/18/2020
Onset Date: 12/20/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Reddening and itching at injection site; Reddening and itching at injection site; Fatigue; This is a spontaneous report from a non-contactable consumer. A 61-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Solution for injection (lot number and expiry date unknown) via an unspecified route of administration on 18Dec2020 in the left arm at a single dose for COVID-19 immunization. The patient's medical history included shellfish allergy. The patient is not pregnant at the time of vaccination. Concomitant medication included spironolactone (ALDACTONE), dextrin (BENEFIBER), folic acid, atorvastatin (LIPITOR), bifidobacterium bifidum, bifidobacterium lactis, bifidobacterium longum, lactobacillus acidophilus, lactobacillus rhamnosus (PROBIOTIC), famotidine (PEPCID), and estradiol (VIVELLE DOT); patient also received these medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to BNT162B2. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 20Dec2020, the patient experienced reddening and itching at injection site and fatigue at 2 days post-inoculation. No therapeutic measures were taken in response to the events. Outcome of the events at the time of last observation was recovered. The report was considered as non-serious; the events did not result in death, were not life threatening, did not caused/prolonged hospitalization, were not disabling/ incapacitating, and did not caused any congenital anomaly/birth defect. No follow-up attempts are possible, information about lot/batch cannot be obtained. No further information is expected.

Other Meds: ALDACTONE [SPIRONOLACTONE]; BENEFIBER [DEXTRIN]; ; LIPITOR [ATORVASTATIN]; PROBIOTIC [BIFIDOBACTERIUM BIFIDUM;BIFIDOBACTERIUM LACTIS;BIFIDOBACTERIUM LONGUM;LACTOBACILLUS ACIDO; PEPCID [FAMOTIDINE]; VIVELLE DOT

Current Illness:

ID: 0952039
Sex: F
Age:
State: PA

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fever; chills; muscle aches; This is a spontaneous report from a contactable nurse. A 22-year-old female patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK9231), intramuscularly on 06Jan2021 at 18:30 at a single dose on the left arm for COVID-19 immunization in the hospital. The patient's medical history and concomitant medications were not reported. The patient previously took spironolactone and had allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. On 07Jan2021 at 05:00, the patient experienced fever, chills, and muscle aches. No treatment was given to the patient. Since the vaccination, the patient has not been tested for COVID-19. The patient was not pregnant at the time of vaccination. The outcome of the events was recovered on an unspecified date in Jan2021. The events were considered non-serious.

Other Meds:

Current Illness:

ID: 0952040
Sex: M
Age:
State: PA

Vax Date: 01/08/2021
Onset Date: 01/09/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: headache; myalgia; fatigue; This is a spontaneous report from a contactable nurse. A 53-year-old adult male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK923), intramuscular on 08Jan2021 16:15 (reported as "04:15 PM") at single dose on the left arm for COVID-19 immunisation. There were no medical history and concomitant medications. No known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications received within 2 weeks of vaccination. Patient was not diagnosed with COVID-19 prior vaccination. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK5730), intramuscular on 18Dec2020 04:30 PM on left arm. COVID-19 vaccine was administered in the hospital. The patient experienced headache, myalgia and fatigue on 09Jan2021 at 8:00 AM. No treatment received for the events. The events were assessed as non-serious. Outcome of the events was recovered in Jan2021. The patient has not been tested for COVID-19 since the vaccination.

Other Meds:

Current Illness:

ID: 0952041
Sex: F
Age:
State:

Vax Date: 01/08/2021
Onset Date: 01/01/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: unilateral cervical lymphadenopathy; seemed to start developing within 24-48 hours after the shot, more noticeable at 72 hours with the pain already improving; myalgia; headache; chills; This is a spontaneous report from a non-contactable physician. A 37-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date unknown), via an unspecified route of administration on 08Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The healthy female patient complained about a unilateral cervical lymphadenopathy (self-examined) on the left side (the same side as the 2nd vaccine shot on Friday 08Jan2021), yesterday evening (Sunday, 10Jan2021). It seemed to start developing within 24-48 hours after the shot, more noticeable at 72 hours with the pain (Jan2021) already improving. She also developed myalgia, headache and chills 12-18 (Jan2021) after the shot. All the other symptoms were somewhat anticipated, but the lymphadenopathy was not. She doesn't have any other conditions. The outcome of lymph node pain was recovering, while the outcome of the remaining events was unknown. No follow-up attempts are possible; information about batch/ lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 0952042
Sex: M
Age:
State: NJ

Vax Date: 12/01/2020
Onset Date: 12/01/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: mild pain at the injection site; This is a spontaneous report from a contactable physician (patient). A 55-year-old male patient received first dose of BNT162B2 (Lot/batch number and expiry date unknown), via an unspecified route of administration on Dec2020 12:00 at single dose in the left arm for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of the Pfizer COVID 19 vaccine three weeks ago at 12:00 noon in the left arm. After the first dose there was mild pain at the injection site which lasted two days and then was gone. The patient did not receive any other vaccines within four weeks prior to the vaccination. The outcome of the event was recovered on Dec2020. The reporter assessed the event as non-serious. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0952043
Sex: U
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: cut to the hand; This is a spontaneous report from a contactable pharmacist. A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient cut his/her hand on an unspecified date with outcome of unknown. The patient received tetanus shot on 07Jan2021, for cut to the hand on an unspecified date. He was due to get 2nd dose of COVID vaccine tomorrow and queried if the patient can receive 2nd dose. Information on Lot/Batch has been requested.

Other Meds:

Current Illness:

ID: 0952044
Sex: U
Age:
State: GA

Vax Date:
Onset Date:
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Name: Heart rate; Result Unstructured Data: Test Result:136

Allergies:

Symptoms: Heart rate of 136; chills; shaking uncontrollably; This is a spontaneous report from a contactable healthcare professional. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; batch/lot number and expiration date unknown), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced heart rate of 136, chills and shaking uncontrollably on an unspecified date. The events took place after use of product. The patient went to the ER and was treated. Therapeutic measures were taken as a result of heart rate of 136, chills and shaking uncontrollably. The outcome of the events was unknown. No follow-up attempts are possible. Information about Lot/Batch cannot be obtained.

Other Meds:

Current Illness:

ID: 0952045
Sex: F
Age:
State: PA

Vax Date:
Onset Date:
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: she had a fever; runny nose; This is a spontaneous report from a contactable consumer (patient's parent) from a Pfizer-sponsored program. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; batch/lot number and expiration date unknown), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. 3 weeks after the first dose, the patient had a fever and runny nose. The reporter would like to know if the patient can take the second dose of the Pfizer COVID vaccine. The outcome of the events was unknown. information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 0952046
Sex: M
Age:
State: FL

Vax Date: 01/06/2021
Onset Date: 01/01/2021
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: ODOR. I am constantly smelling smoke. As if I am holding a cigarette ashtray against my nose when taking deep breath/After the second injection it has intensify; ODOR. I am constantly smelling smoke. As if I am holding a cigarette ashtray against my nose when taking deep breath/After the second injection it has intensify. I now can taste it; This is a spontaneous report from a contactable nurse. A 50-year-old male patient received second dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; lot number: EL1284; expiration date: not known), via an unspecified route of administration on right arm on 06Jan2021 at single dose for covid-19 immunization, administered in hospital. The patient's medical history and concomitant medications were not reported. The patient previously took aspirin and experienced allergies. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. On 16Dec2020 13:30, the patient administered first dose covid vaccine (Lot number: EH9899). On 23Dec2020 13:00, the patient experienced "ODOR". He was constantly smelling smoke. As if he was holding a cigarette ashtray against his nose when taking deep breath. This started a week after the first injection. After the second injection it had intensified. He now could taste it and he felt it went down his throat when he took deep breath. He was hesitated taking deep breath afraid of having an asthma attack or suffocating. The reported events were non-serious. No treatment was received for the events. The outcome of the events was not recovered.

Other Meds:

Current Illness:

ID: 0952047
Sex: F
Age:
State: NM

Vax Date: 12/18/2020
Onset Date: 12/18/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: sore left arm; This is a spontaneous report from a contactable Nurse. 64-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EKS730), intramuscular (IM) on 18Dec2020 at single dose on left upper arm once for COVID-19 immunisation. There were no medical history and concomitant medications. The patient stated that she did not have anything with the first shot except a sore left arm on 18Dec2020. She stated that if she lays on left side it was sore. The event was considered as non-serious. The outcome of the event was not recovered.

Other Meds:

Current Illness:

ID: 0952048
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: arm hurts; body ache; heavy headedness; more tired; This is a spontaneous report from a contactable consumer. A female patient of unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on unspecified date at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. Patient previously received first dose of bnt162b2 on an unspecified date at single dose for COVID-19 immunization and experienced injection site pain, feeling more tired than usual the day off and after and headache. After receiving the second dose, the patient experienced arm hurts way more than last time, a lot more body ache, heavy headedness and just feeling more tired on an unspecified date with outcome of unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 0952049
Sex: F
Age:
State:

Vax Date: 12/24/2020
Onset Date: 12/24/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Sore arm; Fatigue; Patient also breast feeding; Patient also breast feeding; This is a spontaneous report from a non-contactable nurse. This patient reported information for both herself and her baby. This is a mother report. A 33-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 24Dec2020 14:30 at single dose for COVID-19 immunization. Medical history included ongoing breast feeding, asthma, Anaphylaxis to tree nuts. Concomitant medication included bifidobacterium lactis (PROBIOTIC) and prenatal multivitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. For the first dose the patient only had a sore arm and maybe fatigue. No treatment received for the adverse event. She was also breast feeding. Events outcome was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021027460 Mother/Baby case

Other Meds: PROBIOTIC [BIFIDOBACTERIUM LACTIS]

Current Illness: Breast feeding

ID: 0952050
Sex: M
Age:
State: NJ

Vax Date: 12/15/2020
Onset Date: 12/15/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Name: COVID-19 antibody test; Test Result: Negative ; Test Name: COVID-19 PCR test; Test Result: Negative ; Test Name: salivary test; Test Result: Negative

Allergies:

Symptoms: Increasing mild to moderate local tenderness at the deltoid of the injection arm; This is a spontaneous report from a contactable physician. A 53-year-old male patient received the 1st dose of bnt162b2 (BNT162B2) (lot# EH9899), via an unspecified route of administration in right deltoid, on 15Dec2020 at 07:45 AM, at single dose, for COVID-19 immunisation. Medical history included reactive airway disease, Blood pressure abnormal, kidney stones, no sense of taste or smell (Between Dec2019 and Jan2020 or Feb2020), migraine, ongoing obesity (250 to 255 pounds). Family history included migraine (family members). Previously the patient was immunized with diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (TDAP) (booster) in Aug2020, varicella zoster vaccine rge (cho) (SHINGRIX) on 10Aug2020, influenza vaccine (unknown manufacturer) on 12Oct2020, tetanus vaccine (unknown manufacturer) and experienced mild arm soreness. Previously the patient received fluticasone propionate, salmeterol xinafoate (ADVAIR) from Dec2020 and experienced dry mouth and lost sense of taste. Concomitant medications included multivitamin (unknown manufacturer), fluticasone propionate, salmeterol xinafoate (ADVAIR DISKUS INHALER) from 2020 for reactive airway disease, allopurinol (unknown manufacturer) for kidney stones, atorvastatin (unknown manufacturer), potassium (unknown manufacturer); hydrochlorothiazide, valsartan (VALSARTAN AND HYDROCHLOROTHIAZIDE) for blood pressure abnormal, colecalciferol (VITAMIN D). The patient experienced increasing mild to moderate local tenderness at the deltoid of the injection arm on 15Dec2020 with outcome of recovered in Dec2020 (in 36 hours). On unspecified dates the patient underwent lab tests and procedures which included COVID-19 antibody test, COVID-19 PCR test, salivary test: all negative.

Other Meds: ADVAIR DISKUS INHALER; ; ; ; VALSARTAN AND HYDROCHLOROTHIAZIDE; VITAMIN D [COLECALCIFEROL]

Current Illness:

ID: 0952051
Sex: F
Age: 19
State: VA

Vax Date: 10/19/2020
Onset Date: 10/22/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data: Test Date: 20201112; Test Name: Electrocardiogram; Result Unstructured Data: Abnormal; Test Date: 20201221; Test Name: Tilt table test; Result Unstructured Data: confirmed postural orthostatic tachycardia syndrome (POTS)

Allergies:

Symptoms: postural orthostatic tachycardia syndrome; experienced symptoms of syncope; Collapse; Heart palpitations; Dizziness; Initial information regarding an unsolicited valid serious case received from the other healthcare professional via phone at call center (Reference number: US-SANOFI-00426245) on 12-Jan-2021. This case involved a 19-year old female patient who experienced postural orthostatic tachycardia syndrome, after receiving INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED (FLUZONE). Medical history, medical treatment(s), vaccination(s) and family history were not provided. Patient received no concomitant medications. On 19-Oct-2020, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED 0.5 mL multi-dose vial (lot number: UJ477AB, expiry date: 30-Jun-2021) via an unknown route in the right deltoid for prophylactic vaccination. On 22-Oct-2020, 3 days following the suspect product vaccinations, the patient experienced symptoms of syncope, collapse (Fall), heart palpitations (Palpitations), and dizziness. Reporter that the patient had visited the emergency room. After being symptomatic for a while, the patient was seen at the reporting primary care practice on 12-Nov-2020, where an electrocardiogram was performed, which was abnormal. Patient was referred to a neurologist on 11-Dec-2020, Doctor who suspected postural orthostatic tachycardia syndrome (POTS), and the patient was referred to Genetics on 21-Dec-2020. On 21-Dec-2020, 2 months 2 days following the suspect product vaccinations, at genetics, patient underwent a tilt table test, which confirmed postural orthostatic tachycardia syndrome (POTS). Patient had a follow-up appointment with neurologist on 28-Dec-2020. Final diagnosis was postural orthostatic tachycardia syndrome. The event of postural orthostatic tachycardia syndrome associated with accompanying symptoms of syncope, palpitations, dizziness and fall were assessed as important medical event as the accompanying symptom of syncope was assessed as medically significant as per important medical event list. It was not reported if the patient received a corrective treatment. Outcome of the event of postural orthostatic tachycardia syndrome with its accompanying symptoms was unknown. The neurologist and other members of the patient's healthcare team believe that the patients POTS was related to the Fluzone vaccine the patient received.; Sender's Comments: This case involved a 19-year old female patient who presented with postural orthostatic tachycardia syndrome (POTS) accompanied with symptoms of fall, dizziness, syncope and palpitations three days (although diagnosed on a later date) following INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED (FLUZONE). Time to onset is compatible. Although, medical history, comorbidities, concomitant medications, additional information on investigations ruling out other etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of the vaccine cannot be assessed.

Other Meds:

Current Illness:

ID: 0952053
Sex: M
Age:
State: KY

Vax Date: 12/21/2020
Onset Date: 12/21/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: No other AE reported; We have a patient 64 years old who received VARlVAX instead of Shingrix; This spontaneous report was received from a medical assistant and refers to a 64-year-old male patient. No information regarding his pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 21-DEC-2020, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) injection, 0.5 milliliter, lot # T002846, expiration date: 23-JAN-2022 (injection site, route of administration were not provided) for prophylaxis instead of zoster rgE vaccine (mammalian) (SHINGRIX). The doctor knew it was not harmful to the patient that he received the varicella virus vaccine live (oka/merck) (VARIVAX) but he asked when was it safe to revaccinate the patient with zoster rgE vaccine (mammalian) (SHINGRIX) after getting varicella virus vaccine live (oka/merck) (VARIVAX). No other adverse event reported.

Other Meds:

Current Illness: Prophylaxis

ID: 0952054
Sex: U
Age:
State: PA

Vax Date:
Onset Date: 12/10/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: No additional AE/PQC reported; Improperly Stored PROQUAD was administered to patient; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 10-DEC-2020, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant Human albumin (rHA)) (PROQUAD) lot # S021326, expiration date 05-JAN-2021 (dose, route of administration and anatomical location were not reported). Administered dose of vaccine was stored in an unknown improper temperature for unknown period of time. It was unknown by the reporter if there were any previous temperature excursions reported or if digital data logger was involved. There was no additional adverse event reported.

Other Meds:

Current Illness:

ID: 0952055
Sex: U
Age: 1
State: IL

Vax Date: 12/04/2020
Onset Date: 12/04/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: No other AE details available; temperature excursion; This spontaneous report was received from a registered nurse referring to a 11 months old patient of unknown gender. The patient's concomitant medication, pertinent medical history and drug allergies or reactions were not reported. On 04-DEC-2020, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (strength and route of administration were not reported, lot # T017688, expiration date was 21-MAY-2022) 0.5 ml for prophylaxis (product storage error). It was reported that the suspect vaccine was exposed to a temperature of minus 13.3 degree Celsius for a time frame of 4 hours and 15 minutes, as recorded by the digital data logger. There were no previous temperature excursions. No further adverse event (AE) information was provided. This is one of the several reports reported by the same reporter.; Sender's Comments: US-009507513-2012USA013093: US-009507513-2012USA013095: US-009507513-2012USA013501: US-009507513-2012USA013524: US-009507513-2012USA013539: US-009507513-2012USA013585: US-009507513-2012USA013592: US-009507513-2012USA013594: US-009507513-2012USA013598: US-009507513-2012USA013601: US-009507513-2101USA000121: US-009507513-2101USA000122: US-009507513-2101USA000144: US-009507513-2101USA000266:

Other Meds:

Current Illness:

ID: 0952056
Sex: U
Age: 8
State: MI

Vax Date: 12/16/2020
Onset Date: 12/16/2020
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: VARIVAX was administered after temperature excursion; This spontaneous report was received from a medical assistant referring to an 8-year-old patient of unknown gender. Information regarding the patient's pertinent medical history, concomitant medications and drug reactions/allergies was not provided. On 16-DEC-2020, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 mL (lot # T002845, expiration date 23-JAN-2022; strength and route were not reported) for prophylaxis. The improperly stored dose of the suspect vaccine experienced a temperature excursion of -14 degree Celsius to -10 degree Celsius (-12 degree Celsius) for 2 hours and 30 minutes recorded by a data logger. There was no previous temperature excursion. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2101USA002097: US-009507513-2101USA004102: US-009507513-2101USA004159:

Other Meds:

Current Illness:

ID: 0952057
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Muscle pain; This case was reported by a consumer via interactive digital media and described the occurrence of muscle pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced muscle pain. On an unknown date, the outcome of the muscle pain was unknown. It was unknown if the reporter considered the muscle pain to be related to Shingrix. Additional details were provided as follows: The age group was not reported, however it was captured as an adult as per vaccine indication. The age at vaccination was not reported. The reporter stated muscle pain with Shingrix.

Other Meds:

Current Illness:

ID: 0952058
Sex: M
Age: 67
State: MO

Vax Date: 03/01/2020
Onset Date:
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: pain at the injection site; sweating; shivering; fever; body aches; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 68-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix with an associated reaction of hyperhidrosis (1st dose received in December 2019 and he had body aches, pain at the injection site, shivering and fever of 101.9 degrees,refer case US2020244465). In March 2020, the patient received the 2nd dose of Shingrix (intramuscular). In March 2020, 6 hrs after receiving Shingrix, the patient experienced injection site pain, sweating, shivering, fever and general body pain. Rechallenge with Shingrix was positive. In March 2020, the outcome of the injection site pain, sweating, shivering, fever and general body pain were recovered/resolved. It was unknown if the reporter considered the injection site pain, sweating, shivering, fever and general body pain to be related to Shingrix. Additional details were provided as follows: The patient received 2nd dose of Shingrix in left arm. After receiving 2nd dose of Shingrix, the patient experienced fever, body aches, pain at the injection site, shivering, and sweating which lasted about 7 hours. The patient reported the events did not seem as bad with the second dose compared to the first. The reporter did not consent to follow up.; Sender's Comments: US-GLAXOSMITHKLINE-US2020244471:same reporter US-GLAXOSMITHKLINE-US2020244465:same reporter

Other Meds:

Current Illness:

ID: 0952059
Sex: F
Age:
State: FL

Vax Date:
Onset Date:
Rec V Date: 01/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: very sore arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 17th August 2020, unknown after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved. It was unknown if the reporter considered the pain in arm to be related to Shingrix. Additional details were provided as follows: The patient reported for herself. The age at vaccination was not reported. The patient had a very sore arm for 2-3 days after receiving first dose of Shingrix. The reporter consented to follow up. For tolerance of 2nd dose refer case US2020253858.; Sender's Comments: US-GLAXOSMITHKLINE-US2020253858:2nd dose, same reporter

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm